Viridian Therapeutics, Inc. (FRA:1S1)
26.50
+0.71 (2.75%)
At close: Dec 4, 2025
Viridian Therapeutics Employees
Viridian Therapeutics had 143 employees as of December 31, 2024. The number of employees increased by 49 or 52.13% compared to the previous year.
Employees
143
Change (1Y)
49
Growth (1Y)
52.13%
Revenue / Employee
€421,912
Profits / Employee
€1,462,130
Market Cap
2.63B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Viridian Therapeutics News
- 2 days ago - William Blair Initiates Coverage on Viridian Therapeutics (VRDN) with Outperform Rating | VRDN ... - GuruFocus
- 11 days ago - Truist Securities Initiates Coverage on VRDN with Buy Rating | VRDN Stock News - GuruFocus
- 4 weeks ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Wallstreet:Online
- 4 weeks ago - Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - VRDN: RBC Capital Raises Price Target for Viridian Therapeutics to $45.00 | VRDN Stock News - GuruFocus
- 4 weeks ago - Viridian Therapeutics Is Ready For An Eventful 2026 - Seeking Alpha
- 4 weeks ago - DRI Healthcare Reports Third Quarter 2025 Results - Benzinga
- 4 weeks ago - Viridian Therapeutics GAAP EPS of -$0.34 beats by $0.68, revenue of $70.57M - Seeking Alpha